Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression.

Hou YC, Lai CH.

Clin Psychopharmacol Neurosci. 2014 Aug;12(2):163-5. doi: 10.9758/cpn.2014.12.2.163. Epub 2014 Aug 12.

2.

Quetiapine fumarate (Seroquel): a new atypical antipsychotic.

Goldstein JM.

Drugs Today (Barc). 1999 Mar;35(3):193-210.

PMID:
12973385
3.

Quetiapine in tardive dyskinesia.

Chari S, Jainer A, Ashley-Smith A, Cleaver M.

Int J Psychiatry Clin Pract. 2002;6(3):175-7. doi: 10.1080/136515002760276126.

PMID:
24945206
4.
5.

Tardive Blepharospasm and Meige Syndrome during Treatment with Quetiapine and Olanzapine.

Kiliç A, Erten E, Özdemir A.

Noro Psikiyatr Ars. 2015 Jun;52(2):207-209. doi: 10.5152/npa.2015.7411. Epub 2015 Jun 1.

6.

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.

Peritogiannis V, Tsouli S.

J Psychopharmacol. 2010 Jul;24(7):1121-5. doi: 10.1177/0269881109103827. Epub 2009 Apr 24.

PMID:
19395427
7.

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

Barnes TR, McPhillips MA.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. Review.

PMID:
9690971
8.

Relapse of tardive dyskinesia due to reduction in clozapine dose.

Shrivastava M, Solanke B, Dakhale G, Somani A, Waradkar P.

Indian J Pharmacol. 2009 Aug;41(4):201-2. doi: 10.4103/0253-7613.56067.

9.

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

J Clin Psychiatry. 2004 May;65(5):696-701.

PMID:
15163258
10.

[Utility of quetiapine in tardive dyskinesia].

Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.

Actas Esp Psiquiatr. 2003 Nov-Dec;31(6):347-52. Review. Spanish.

PMID:
14639511
11.

Tardive dyskinesia in a patient treated with quetiapine.

Rizos E, Douzenis A, Gournellis R, Christodoulou C, Lykouras LP.

World J Biol Psychiatry. 2009;10(1):54-7.

PMID:
19673087
12.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
13.

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R, Annable L.

Can J Psychiatry. 2005 Oct;50(11):703-14. Review.

PMID:
16363464
14.

Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.

Ono S, Suzuki Y, Shindo M, Endo T, Fukui N, Sugai T, Someya T.

J Clin Pharm Ther. 2012 Jun;37(3):370-2. doi: 10.1111/j.1365-2710.2011.01290.x. Epub 2011 Oct 24. Review.

PMID:
22023382
15.

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.

Nelson MW, Reynolds RR, Kelly DL, Conley RR.

Clin Neuropharmacol. 2003 Nov-Dec;26(6):297-8.

PMID:
14646608
16.

Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.

Glazer WM.

J Clin Psychiatry. 2000;61 Suppl 3:16-21. Review.

17.
18.

Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.

Gourzis P, Polychronopoulos P, Papapetropoulos S, Assimakopoulos K, Argyriou AA, Beratis S.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):195-6.

PMID:
16062102
19.
20.

Maintenance treatment of severe tardive dyskinesia with clozapine: 5 years' follow-up.

Louzã MR, Bassitt DP.

J Clin Psychopharmacol. 2005 Apr;25(2):180-2.

PMID:
15738751

Supplemental Content

Support Center